NR2E3 and acute myeloid leukemia: The reduced EdU incorporation, upregulated r-H2Ax level, increased cell cycle arrest in S phase and reversibility by dNTP precursors, the dose-dependent cell viability inhibition and apoptosis induction together indicated that the compound inhibited DNA synthesis and thereby cell proliferation by inhibiting RNR activity in treated AML cells.